News

A study with the participation of the CSIC reveals that the frequency of having an altered immune response that prevents coping with COVID-19 increases with age.

The study shows that there is a probability of developing the wrong antibodies or autoantibodies, which attack the immune system.

Read More

IIBB Researchers Lead A Consensus Statement Of Drug Induced Liver Injury Under The Support Of The European Network [Pro-Euro-Dili-Net]

Drug induced liver injury (DILI) is a major cause of acute liver failure (ALF) and one of the leading indications for liver transplantation in Western societies.

Read More

IIBB researchers discover a new regulatory mechanism of STARD1 in Niemann-Pick disease type C (NPC).

 

Read More

A project with the participation of IIBB-CSIC researchers receives funding from La Marató de TV3 against COVID-19

In this year's call for La Marató de TV3 dedicated to fighting COVID-19, 229 proposals have been presented, of which 36 have been selected.

Read More

Doctor Francesc Artigas has been awarded the premi SCB Trajectòria Professional Leandre Cervera 2021

Read More

Oligonucleotide therapeutics as a new class of treatment for brain diseases

Messenger RNA (mRNA) is becoming an increasingly important target for therapeutic intervention. The mRNA molecule transmits information directly from the genome.

Read More

April 11 - World Parkinson's Disease Day at the IIBB (video)

Parkinson's disease is the second most common neurodegenerative disease after Alzheimer’s disease and is characterized by a progressive loss of neurons involved in the control of movement.

Read More

Pages